Polypills for the Secondary Prevention of Cardiovascular Disease: Effective in Improving Adherence but Are They Safe?

Therapeutic Advances in Drug Safety - United Kingdom
doi 10.1177/2042098617747836
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

SAGE Publications

Related search

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

The Role of mHealth Technology in the Secondary Prevention of Cardiovascular Disease

Romanian Biotechnological Letters
2019English

Sublaminar Bands: Are They Safe?

European Spine Journal
SurgeryOrthopedicsSports Medicine
2014English

Omega-3 Fatty Acids for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2020English

Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for Thromboembolic Prevention, Are They Safe in Congenital Heart Disease? Results of a Worldwide Study

International Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Barriers to Medication Adherence in Patients Prescribed Medicines for the Prevention of Cardiovascular Disease: A Conceptual Framework

International Journal of Pharmacy Practice
EnvironmentalPublic HealthPharmacyHealth PolicyPharmaceutical ScienceMedicineOccupational Health
2018English

Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease

Cardiology in Review
MedicineCardiovascular MedicineCardiology
2016English

Aspirin for Prevention of Cardiovascular Disease

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy